Pancreatic Cancer Research

ResearcherUniversity of Oklahoma Health Sciences CenterActive in the last 2 years

Hao Yuan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-4848-3354; OpenAlex author ID A5108579714. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. Mitophagy-Competent Cancer-Associated Fibroblasts Fuel Chemoresistance by Rewiring Pyrimidine Metabolism in Pancreatic Cancer. First author DOI 10.1158/0008-5472.can-25-5716↗
  2. Shared HLA-Bound Neoepitopes Are New Targets for Pancreatic Cancer Immunotherapy. Co-author DOI 10.1158/1078-0432.ccr-24-4368↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Min Li · 2 shared papers, 2025–2026 · strength 0.57
  2. Courtney W. Houchen · 2 shared papers, 2025–2026 · strength 0.57
  3. Yuqing Zhang · 1 shared paper, 2025 · strength 0.30
  4. Qun Chen · 1 shared paper, 2025 · strength 0.30
  5. Kuirong Jiang · 1 shared paper, 2025 · strength 0.30
  6. Shaobo Zhang · 1 shared paper, 2026 · strength 0.26
  7. Zhijun Zhou · 1 shared paper, 2026 · strength 0.26
  8. Haoran Qi · 1 shared paper, 2026 · strength 0.26
  9. Mingyang Liu · 1 shared paper, 2026 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.